The table below shows Autolus Therapeutics plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$26.22M
$21.19M
$20.92M
$8.98M
$0.00
$0.00
Cost of revenue
$24.57M
$28.64M
$24.45M
$17.95M
$0.00
$0.00
Gross profit
-
-
-
-
-
-
R&D
$21.21M
$27.89M
$27.43M
$26.73M
$40.32M
$36.61M
AUTL annual revenue (10-K history)
Autolus Therapeutics plc reported annual revenue of $75.39M for fiscal year 2025. That is up 644.9% from $10.12M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $1.21M (FY 2016) to $75.39M. Figures come from the company's audited annual reports as filed with the SEC.